Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

China updates drug reimbursement list, agrees price cuts

China updates drug reimbursement list, agrees price cuts Drugs added include AbbVie's Humira and Roche's Perjeta. Chinese regulators have added 70 new medicines to the country’s National Reimbursement Drug List (NRDL), and has agreed an average ... The key drugs which have been added to the list include

Seattle Genetics preps filing next year for oral HER2 drug

Seattle Genetics preps filing next year for oral HER2 drug Herceptin plus Xeloda is a standard regimen for HER2-positive breast cancer in patients previously treated with Herceptin and Roche’s other  HER2-targeting drugs Perjeta (pertuzumab) and Kadcyla (ado-trastuzumab

AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs

AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs Although it has crossed the blockbuster threshold this year, Kadcyla is still the runt of Roche’s HER2 litter lagging well behind Herceptin (trastuzumab) and Perjeta (pertuzumab) in sales terms. ... in order to move it into earlier lines of treatment

Roche reports continued growth in Q3, despite biosimilar competition

Roche reports continued growth in Q3, despite biosimilar competition According to the Swiss pharma, the key drivers of this growth were mutliple sclerosis medicine  Ocrevus, new haemophilia treatment  Hemlibra and its cancer medicines – Tecentriq, Perjeta and Avastin. ... The sales increase in US stood at 14%, led by

SMC approves Yescarta and Keytruda, rejects Perjeta

SMC approves Yescarta and Keytruda, rejects Perjeta sales. Not-so-lucky was Roche’s Perjeta (pertuzumab), which has been handed a rejection by the SMC. ... Perjeta has patent protection until 2023 in Europe and 2024 in the US, so Roche will be hoping to continue to push the drug into new areas and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics